Overview
Ocrevus Zunovo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, active…
Overview
As many as 80 percent of people with multiple sclerosis (MS) choose to incorporate non-traditional therapies into their treatment plan. These treatments may be in addition to (complementary) or instead of… read more